Preserving Muscle Strength to Maximize the Impact of GLP-1s in Obesity Management

11:30 am - Wednesday 9th December 2026

  • Combining a novel oral therapy with GLP-1s to deliver additional weight loss while improving muscle strength throughout treatment
  • Targeting the underlying drivers of muscle regeneration to support healthy weight loss and functional independence
  • Enhancing muscle quality and repair alongside weight reduction to improve long-term outcomes for older adults with obesity

Speakers:

Founder & Chief Executive Officer
Ridgeline Therapeutics